{"disease":{"id":"short-children-born-small-for-gestational-age-sga","name":"short children born small for gestational age sga"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01491854","title":"Long-term Safety Follow-up After Growth Hormone Treatment of Short Children Born Small for Gestational Age","phase":"NA","overall_status":"TERMINATED","enrollment_count":130,"lead_sponsor_name":"Sandoz","has_results":true},{"nct_id":"NCT07260500","title":"A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, and Pharmacokinetics","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":72,"lead_sponsor_name":"Changchun GeneScience Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT03878446","title":"A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":62,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}